Femasys inc. receives u.s. fda clearance to market femaseed, an innovative infertility treatment solution

- the 510(k) clearance from the united states food and drug administration (fda) allows for the u.s. commercialization of femaseed ® , an intratubal artificial insemination option designed to augment the natural fertilization process -

FEMY Ratings Summary

FEMY Quant Ranking